✦ LIBER ✦

A follow-up study on chemoimmunotherapy (5-fluorouracil and BCG) in advanced gastric cancer

✍ Scribed by T. Popiela; M. Zembala; J. Oszacki; W. Jedrychowski

Publisher: Springer-Verlag
Year: 1982
Tongue: English
Weight: 290 KB
Volume: 13
Category: Article
ISSN: 0340-7004
DOI: 10.1007/bf00205385

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A controlled study of maintenance chemoi

A controlled study of maintenance chemoimmunotherapy vs immunotherapy alone immediately following palliative gastrectomy and induction chemoimmunotherapy for advanced gastric cancer

✍ M. Yasue; M. Murakami; H. Nakazato; T. Suchi; K. Ota 📂 Article 📅 1981 🏛 Springer 🌐 English ⚖ 447 KB

A randomized trial of surgical adjuvant chemoimmunotherapy was conducted in patients who had undergone palliative gastrectomy for previously untreated advanced stomach cancer. First, all patients received the same induction chemoimmunotherapy with MFC (mitomycin C, 5-fluorouracil, and cytosine arabi

Modified therapy with 5-fluorouracil, do

Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer

✍ Andre M. Murad; Flavia F. Santiago; Andy Petroianu; Paulo R. S. Rocha; Marco A. 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 518 KB

Advanced gastric cancer: Experience in S

Advanced gastric cancer: Experience in Scotland using 5-fluorouracil, adriamycin and mitomycin-C

✍ Dr D. Cunningham; M. Soukop; C. S. McArdle; D. C. Carter; J. F. Smyth; S. G. All 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 402 KB

A phase III randomized study of 5-fluoro

A phase III randomized study of 5-fluorouracil and cisplatin versus 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil alone in the treatment of advanced gastric cancer

✍ Noe Kyeong Kim; Young Suk Park; Dae Seog Heo; Cheolwon Suh; Si Young Kim; Keun C 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 576 KB

Further studies on the treatment of adva

Further studies on the treatment of advanced gastric cancer by 5-fluorouracil, adriamycin (Doxorubicin), and mitomycin C (modified FAM)

✍ Nissim Haim; Ron Epelbaum; Yoram Cohen; Eliezer Robinson 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 359 KB 👁 2 views

Randomized study with mitomycin C + 5-fl

Randomized study with mitomycin C + 5-fluorouracil + cytosine arabinoside (MFC) + 5-fluorouracil, MFC + tegafur and uracil (UFT), and MF + UFT in advanced gastric cancer: Interinstitutional differences in a multicenter study in Japan

✍ Hiroshi Furukawa; Takeshi Iwanaga; Toshifusa Nakajima; Kenzo Okabayashi; Hiroaki 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 437 KB

In a phase 111 randomized trial of adjuvant chemotherapy for gastric cancer, interinstitutional differences were analyzed. A trial of three regimens: mitomycin C, 5-fluorouracil(5-FU) and CA (MFC) + continuous oral 5-FU (Group C); MFC + continuous oral UFT(tegafur and uracil) (Group B); and MF + UFT